企业QQ
官方微信
HiSeqXReagentKitssupporthighcoveragewhole-genomesequencing(WGS)withtheHiSeqXSeriesofsequencingsystems.Byleveragingpatternedflowcells,thesekitsprovideincreasedclusterdensitytoenablesignificantincreasesindataoutputanddailythroughput.HiSeqXReagentKitssupportindustry-leADInglibrarypreparationoptionswhileofferingsuperiordataqualityandcoverage.
HiSeqXReagentKitssupporttheTruSeqDNAPCR-FreeLibraryPreparationKit,forindustry-bestcoverageofchallenginggenomicregions,andtheTruSeqNanoDNALibraryPreparationKit,forefficientsequencingofsampleswithlimitedavailableDNA.Together,thereagentkitsandlibrarypreparationoptionsdeliverexceptionalgenomecoverage,enablinghighlyaccurateandcomprehensivevariantcallingforWGSontheHiSeqXTenandtheHiSeqXFiveSystems.TheHiSeqXReagentKits:
Deliverultra-highdataoutputProvideultra-highdailythroughputEnablesequencingupto16genomesperrunAreavailableinsingleandmultipackconfigurationsArecompatIBLewithTruSeqDNAPCR-FreeandTruSeqNanoDNALibraryPreparationKitsHiSeqXReagentKitsareonlycompatiblewiththeHiSeqXSeriesofsequencingsystems.HiSeqXTenReagentKitsareonlyavailableforpurchasebyHiSeqXTenusersandtheHiSeqXFiveReagentKitsareonlyavailableforpurchasebyHiSeqXFiveusers.Reagentsarealsoavailableinamultipackconfigurationtosupportbulkpurchasingwithsignificantreductionsinpackagingmaterials.
Latesttechnologyinnovationpowerspopulation-scalesequencingHiSeqXReagentKitsleveragethenewestformatinIlluminaflowcelltechnologytoachieveultra-high-throughputWGS.Patternedflowcellscontainbillionsofnanowellsubstratesatfixedlocationsacrossbothsurfacesoftheflowcell.Thestructuredorganization(seebelow)providesevenspacingofsequencingclusterstodeliversignificantincreasesinsequencingreadsandtotaloutputofthesystem.
Specifications:MaximumOutputUpto1800Gb(1HiSeqXSystemwithdualflowcells)MaximumReadsperRunUpto6billionReagentTypePaired-EndSequencing,ClusterGenerationSystemCompatibilityHiSeqXTen,HiSeqXFiveTechnologySequencingIllumina公司，致力于新一代测序和芯片技术的生产与开发，提供最新的产品与应用资讯。Illumina公司创立于1998年4月，是遗传变异和生物学功能分析领域的优秀的产品、技术和服务供应商。通过帮助客户加快实现生物信息的采集、分析和应用，来改善人类健康。
Asastartup,Illuminaaspiredtotransformhumanhealth.OurinitialproductsenabledresearcherstoexploreDNAatanentirelynewscale,helpingthemcreatethefirstmapofgenevariationsassociatedwithhealth,disease,anddrugresponse.Everybreakthroughopenedupanewworld,andshowedushowmuchfurtherthereistogo
Whiletherateofprogressisacceleratingexponentially,weareonlybeginningtounderstandtheclinicalsignificanceofthegenome.Whatcausesacancercelltomutate?Whatistheoriginofapuzzlingdisease?Isitpossibletopreventthenextoutbreak?Orsafeguardtheworld’sfoodsupply?Thesearejustafewofthechallengesthatinspireustopushtheboundariesofourimagination
Todayweareagloballeaderingenomics–anindustryattheintersectionofBIOLOGyandtechnology.Atthemostfundamentallevel,weenableourcustomerstoreadandunderstandgeneticvariations.Westrivetomakeoursolutionsincreasinglysimple,moreaccessible,andalwaysreliable.Asaresult,discoveriesthatwereunimaginableevenafewyearsagoarenowbecomingroutine–andaremakingtheirwayintopatienttreatment.
Wenowhavetheabilitytosequenceatanunprecedentedscale.Collectively,thiswillgiveusamuchdeeperunderstandingofgeneticsthaneverbefore.Wewillbegintotrulyunlockthepowerofthegenome.Theseadvanceswilltriggerafundamentalshiftinhealthcareandbeyond.Medicinewillcontinuetobecomemorepreventiveandmoreprecise.Wewillbehealthier,longer.Wehaveonlyjustbegun.
AtIllumina,ourgoalistoapplyinnovativetechnologiestotheanalysisofgeneticvariationandfunction,makingstudiespossiblethatwerenotevenimaginablejustafewyearsago.Itismissioncriticalforustodeliverinnovative,flexible,andscalablesolutionstomeettheneedsofourcustomers.Asaglobalcompanythatplaceshighvalueoncollaborativeinteractions,rapiddeliveryofsolutions,andprovidingthehighestlevelofquality,westrivetomeetthischallenge.Illuminainnovativesequencingandarraytechnologiesarefuelinggroundbreakingadvancementsinlifescienceresearch,translationalandconsumergenomics,andmoleculardiagnostics